GlassScriptPhysician profile
Rachel Lev
NPI 1578324356
$1,504.55
in general payments reported to CMS, 2019-2025
17 companies · $721 in 2025
The $721 reported for 2025 was more than what 93% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $130 · 2024: $654 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,406 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,405.55 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $304.03 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $236.92 | 2024-2025 | |
| Hologic Sales and Service, LLC | $153.77 | 2024-2025 | Aptima, Myosure Tissue Removal Device, Acessa Provu System |
| Acella Pharmaceuticals, LLC | $130.01 | 2023 | NP Thyroid 60 |
| Abbvie INC. | $96.93 | 2025 | |
| Exeltis, USA INC. | $87.19 | 2024-2025 | Slynd |
| Exact Sciences Corporation | $85.48 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $84.38 | 2024-2025 | Myfembree |
| Millicent US INC | $67.87 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Agile Therapeutics, INC. | $46.66 | 2024 | Twirla |
| Novo Nordisk INC | $46.36 | 2025 | Wegovy |
| Vertex Pharmaceuticals Incorporated | $42.06 | 2024-2025 | |
| Coopersurgical, INC. | $36.85 | 2025 | Paragard T 380a |
| Visby Medical, INC. | $26.54 | 2024 | Visby Medical Sexual Health Click Test, Visby Medical Respiratory Health Test |
| Bayer Healthcare Pharmaceuticals INC. | $21.48 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $19.86 | 2024 | Bulkamid, Axonics |
| Lilly USA, LLC | $18.16 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Lev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.